Results 161 to 170 of about 46,950 (237)
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Ophthalmoplegia as Sole Manifestation of Myasthenia Gravis over Twenty-Five Years [PDF]
, 1941 C. J. Gavey
openalex +1 more source
Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review
Clinical Oral Implants Research, EarlyView.ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl +2 more
wiley +1 more source
Wearable sensors in paediatric neurology
Developmental Medicine &Child Neurology, EarlyView.Types of signals monitored in children's natural environments using wearable sensors, and their associated applications in various paediatric neurological conditions. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16267 Abstract Wearable sensors have the potential to transform diagnosis, monitoring, and management of children ...
Camila González Barral, Laurent Servais
wiley +1 more source
Schizophrenia is a TH2 dominant autoimmune disease possibly against acetylcholine receptors of CNS [PDF]
, 2012 Schizophrenia is a very common psychiatric disorder. However, its etiology and pathogenesis is still unknown. Current theory saying that neurotransmitter imbalance such as serotonin or dopamine only provides limited effectiveness in schizophrenia ...
Wanchung(Wan-Jiung) Hu
core +1 more source
THE INTRA-ARTERIAL INJECTION OF NEOSTIGMINE AS A DIAGNOSTIC TEST IN MYASTHENIA GRAVIS [PDF]
, 1953 E. C. Hutchinson, W.B. Matthews
openalex +1 more source
Disfagia e Disartria. Forma Invulgar de Apresentação da Miastenia Gravis [PDF]
, 2007 Myasthenia Gravis is an autoimmune disorder that generally presents with ocular symptoms, specially diplopia and ptosis. Dysphagia may be a manifestation of the generalised type of the disease, but rarely is its presenting feature. The authors describe a
Alcântara, J +5 more
core
Thymectomy in the treatment of ocular myasthenia gravis [PDF]
Background: Thymectomy is an effective and accepted treatment for myasthenia gravis, but thymectomy for ocular myasthenia gravis (Osserman stage I) is controversial.
Benfield, John R. +7 more
core +1 more source